What is Delek US's operating income?

Delek US's total operating income in 2025 was $301 million, based on the following breakdown: Total Gross Profit: $612.10 million Total Operating Expenses: $311.10 million

Delek US (DK) Financials

$68.22 +1.00 (+1.49%)

Closing price 08/13/2026 03:59 PM Eastern

Extended Trading

$68.60 +0.39 (+0.56%)

As of 06:36 AM Eastern

Compare

Annual Income Statements for Delek US

This table shows Delek US's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	19	-154	289	340	311	-611	-128	257	20	-560	-23
Consolidated Net Income / (Loss)	44	-133	323	375	336	-574	-95	291	47	-521	43
Net Income / (Loss) Continuing Operations	37	-220	329	384	331	-574	-95	265	20	-598	46
Total Pre-Tax Income	21	-391	299	486	403	-767	-137	322	17	-706	39
Total Operating Income	69	-49	180	612	492	-732	-35	458	245	-492	301
Total Gross Profit	545	32	432	973	890	-261	251	748	549	-43	612
Total Revenue	4,782	4,198	7,267	10,233	9,298	7,302	10,648	19,801	16,467	11,852	10,723
Operating Revenue	4,782	4,198	7,267	10,233	9,298	7,302	10,648	19,801	16,467	11,852	10,723
Total Cost of Revenue	4,237	4,166	6,835	9,260	8,408	7,563	10,398	19,053	15,919	11,895	10,111
Operating Cost of Revenue	4,237	4,166	6,835	9,260	8,408	7,563	10,398	19,053	15,919	11,895	10,111
Total Operating Expenses	476	81	251	361	398	471	285	290	304	448	311
Selling, General & Admin Expense	371	106	176	248	275	235	200	314	272	253	270
Depreciation Expense	106	10	21	38	24	26	25	11	17	25	24
Other Operating Expenses / (Income)	-0.50	7.10	54	75	100	85	83	-3.50	-2.50	-52	0.50
Impairment Charge	-	0.00	0.00	0.00	0.00	126	0.00	0.00	38	244	18
Other Special Charges / (Income)	0.00	-42	-	-	-	0.00	-23	-31	-20	-21	-0.10
Total Other Income / (Expense), net	-47	-342	119	-126	-90	-35	-103	-136	-228	-215	-262
Interest & Investment Income	3.10	-287	17	16	46	30	18	-138	-232	-221	-256
Other Income / (Expense), net	1.60	-0.40	196	-6.90	-4.10	60	16	2.40	3.70	6.30	-6.30
Income Tax Expense	-16	-172	-29	102	72	-194	-42	56	-3.00	-108	-6.80
Net Income / (Loss) Discontinued Operations	6.60	86	-5.90	-8.70	5.20	-	-	25	27	77	-2.40
Net Income / (Loss) Attributable to Noncontrolling Interest	24	20	34	35	26	38	33	33	27	40	66
Basic Earnings per Share	$0.32	($2.49)	$4.04	$4.11	$4.10	($8.31)	($1.73)	$3.63	$0.30	($8.77)	($0.38)
Weighted Average Basic Shares Outstanding	60.82M	61.92M	71.57M	82.80M	75.85M	73.60M	73.98M	70.79M	65.41M	63.88M	60.70M
Diluted Earnings per Share	$0.32	($2.49)	$4.00	$3.95	$4.06	($8.31)	($1.73)	$3.59	$0.30	($8.77)	($0.38)
Weighted Average Diluted Shares Outstanding	61.32M	61.92M	72.30M	86.77M	76.57M	73.60M	73.98M	71.52M	65.41M	63.88M	60.70M
Weighted Average Basic & Diluted Shares Outstanding	-	-	83.92M	78.01M	73.41M	73.78M	74.20M	66.94M	64.02M	62.51M	59.81M
Cash Dividends to Common per Share	$0.60	$0.60	$0.60	$0.96	$1.14	$0.93	$0.00	$0.61	$0.93	$1.01	$1.02

This table shows Delek US's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Income / (Loss) Attributable to Common Shareholders	-165	-33	-37	-77	-414	-173	-106	178	78	-201	170
Consolidated Net Income / (Loss)	-160	-25	-26	-68	-402	-159	-90	195	97	-191	180
Net Income / (Loss) Continuing Operations	-177	-28	-34	-135	-412	-158	-89	195	98	-191	180
Total Pre-Tax Income	-221	-36	-43	-175	-465	-195	-103	235	102	-249	222
Total Operating Income	-160	29	4.60	-122	-416	-126	-34	296	165	-179	302
Total Gross Profit	-124	95	17	-20	-210	-64	52	398	226	-130	365
Total Revenue	3,719	3,128	3,308	3,042	2,161	2,642	2,765	2,887	2,429	2,653	4,087
Operating Revenue	3,719	3,128	3,308	3,042	2,161	2,642	2,765	2,887	2,429	2,653	4,087
Total Cost of Revenue	3,843	3,033	3,291	3,063	2,370	2,706	2,712	2,489	2,204	2,783	3,722
Operating Cost of Revenue	3,843	3,033	3,291	3,063	2,370	2,706	2,712	2,489	2,204	2,783	3,722
Total Operating Expenses	36	66	12	102	206	62	86	102	61	49	63
Selling, General & Admin Expense	57	61	60	70	55	62	77	77	55	44	57
Depreciation Expense	-0.70	5.30	7.70	5.60	-1.00	6.30	6.50	5.50	5.20	5.70	4.50
Other Operating Expenses / (Income)	-38	-0.60	-78	17	-39	-5.70	2.60	3.40	0.20	-0.60	1.50
Total Other Income / (Expense), net	-61	-65	-47	-53	-49	-69	-70	-61	-62	-70	-81
Interest & Investment Income	-217	-66	-47	-54	-219	-71	-64	-62	-59	-70	-80
Other Income / (Expense), net	-0.90	0.60	0.00	0.50	5.10	1.60	-6.20	1.20	-2.90	0.30	-0.10
Income Tax Expense	-44	-7.60	-8.80	-40	-53	-37	-14	40	4.20	-58	42
Net Income / (Loss) Discontinued Operations	-	3.20	7.70	67	-	-0.30	-0.80	-0.30	-1.00	-0.20	0.00
Net Income / (Loss) Attributable to Noncontrolling Interest	4.80	7.40	11	9.30	12	14	16	17	19	10	11
Basic Earnings per Share	($2.51)	($0.51)	($0.58)	($1.20)	($6.48)	($2.78)	($1.76)	$2.96	$1.20	($3.34)	$2.76
Weighted Average Basic Shares Outstanding	65.41M	64.02M	64.21M	64.06M	63.88M	62.12M	60.51M	60.19M	60.70M	60.26M	61.32M
Diluted Earnings per Share	($2.49)	($0.51)	($0.58)	($1.20)	($6.48)	($2.78)	($1.76)	$2.93	$1.23	($3.34)	$2.71
Weighted Average Diluted Shares Outstanding	65.41M	64.02M	64.21M	64.06M	63.88M	62.12M	60.51M	60.94M	60.70M	60.26M	62.49M
Weighted Average Basic & Diluted Shares Outstanding	64.02M	64.13M	64.54M	63.20M	62.51M	60.73M	60.15M	60.05M	59.81M	61.29M	61.23M

This table details how cash moves in and out of Delek US's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-142	387	253	137	-124	-168	69	-15	-19	-87	-110
Net Cash From Operating Activities	180	248	320	560	575	-283	371	425	1,014	-67	536
Net Cash From Continuing Operating Activities	144	235	322	590	575	-283	371	394	979	-84	538
Net Income / (Loss) Continuing Operations	37	-220	329	375	336	-574	-95	265	20	-598	46
Consolidated Net Income / (Loss)	44	-133	323	375	336	-574	-95	291	47	-521	43
Net Income / (Loss) Discontinued Operations	6.60	86	-5.90	-	-	-	-	25	27	77	-2.40
Depreciation Expense	106	116	153	199	194	268	265	275	340	375	398
Non-Cash Adjustments To Reconcile Net Income	-4.50	366	-24	-85	101	2.10	284	167	-87	294	15
Changes in Operating Assets and Liabilities, net	1.30	-32	-136	101	-56	21	-82	-314	707	-154	80
Net Cash From Discontinued Operating Activities	36	13	-2.10	-30	-	-	-	32	35	17	-2.40
Net Cash From Investing Activities	-460	201	38	-125	-691	-191	-178	-932	-408	-242	-698
Net Cash From Continuing Investing Activities	-435	-88	25	-145	-691	-191	-178	-901	-382	-603	-698
Purchase of Property, Plant & Equipment	-188	-46	-172	-322	-413	-269	-222	-280	-393	-428	-530
Acquisitions	-249	-62	185	-1.90	-287	-34	-2.70	-631	-4.30	-205	-196
Purchase of Investments	-	-	-	-	-	-	0.00	0.00	-12	0.00	0.00
Sale of Property, Plant & Equipment	1.20	0.20	0.10	67	16	0.20	12	0.20	1.90	10	10
Sale and/or Maturity of Investments	-	20	12	1.20	0.80	72	10	9.90	15	5.00	16
Other Investing Activities, net	-	-	0.00	0.00	-8.00	0.00	24	0.00	10	14	1.40
Net Cash From Discontinued Investing Activities	-25	289	12	20	-	-	-	-30	-26	362	0.00
Net Cash From Financing Activities	139	-62	-105	-298	-7.90	306	-124	491	-625	222	52
Net Cash From Continuing Financing Activities	91	-44	-105	-298	-7.90	306	-124	491	-625	222	52
Repayment of Debt	-417	-385	-1,350	-2,520	-1,590	-1,922	-2,755	-4,831	-5,232	-8,934	-12,167
Repurchase of Preferred Equity	-	-	-	-	-	-	-	0.00	0.00	-71	0.00
Repurchase of Common Equity	-42	-6.00	-25	-365	-178	-1.90	0.00	-194	-85	-42	-79
Payment of Dividends	-58	-62	-87	-80	-87	-98	0.00	-79	-60	-64	-62
Issuance of Debt	612	409	1,408	2,815	1,869	2,068	1,739	4,635	3,546	7,981	10,571
Issuance of Common Equity	-	-	-	-	0.00	0.00	0.00	3.10	0.00	298	0.00
Other Financing Activities, net	-2.90	-1.10	-51	-148	-23	260	892	956	1,207	1,054	1,789
Cash Interest Paid	49	52	82	120	126	124	125	189	329	305	354
Cash Income Taxes Paid	5.10	1.70	71	104	94	3.60	4.20	28	11	3.80	1.50

This table details how cash moves in and out of Delek US's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Change in Cash & Equivalents	-80	-69	-96	380	-302	-112	-8.30	15	-5.10	-1.70	4.50
Net Cash From Operating Activities	91	167	-48	-22	-164	-62	51	44	503	461	263
Net Cash From Continuing Operating Activities	87	161	-48	-39	-163	-62	52	44	504	461	263
Net Income / (Loss) Continuing Operations	-163	-28	-26	-146	-401	-158	-89	195	98	-191	180
Consolidated Net Income / (Loss)	-160	-25	-26	-68	-402	-159	-90	195	97	-191	180
Depreciation Expense	84	92	92	91	96	101	94	101	101	103	116
Non-Cash Adjustments To Reconcile Net Income	-8.00	101	-2.80	-76	270	35	-39	-255	274	100	-94
Changes in Operating Assets and Liabilities, net	174	-3.50	-112	91	-128	-40	86	3.30	30	449	61
Net Cash From Investing Activities	-69	-42	-63	78	-216	-315	-163	-103	-117	-190	-176
Net Cash From Continuing Investing Activities	-61	-33	-63	-283	-216	-315	-163	-103	-117	-190	-176
Purchase of Property, Plant & Equipment	-72	-38	-86	-104	-191	-136	-166	-108	-120	-188	-174
Acquisitions	-1.70	-0.70	-0.60	-178	-25	-186	-2.50	-1.90	-5.60	-5.90	-3.30
Sale of Property, Plant & Equipment	0.60	0.00	-	1.10	-0.40	4.30	0.60	0.20	5.20	0.10	0.10
Sale and/or Maturity of Investments	4.40	2.80	0.60	0.70	0.90	2.10	3.50	6.50	3.60	5.00	3.10
Other Investing Activities, net	8.80	3.60	14	-2.50	-1.30	0.50	1.20	-0.20	-0.10	-1.80	-2.30
Net Cash From Financing Activities	-101	-194	15	323	77	265	103	75	-391	-273	-82
Net Cash From Continuing Financing Activities	-101	-194	15	323	77	265	103	75	-391	-273	-82
Repayment of Debt	-1,265	-2,254	-1,832	-2,047	-2,505	-2,848	-3,874	-2,889	-2,851	-3,615	-4,910
Repurchase of Common Equity	-20	0.00	-	-20	-22	-32	-13	-15	-20	0.00	-20
Payment of Dividends	-15	-16	-6.20	-16	-16	-38	-16	-15	-15	-38	6.50
Issuance of Debt	930	2,143	1,723	2,734	1,382	2,820	3,254	2,152	2,345	3,112	4,588
Other Financing Activities, net	269	-200	131	-328	1,143	362	751	842	151	269	254
Cash Interest Paid	97	75	70	88	71	98	69	96	94	90	81

This table presents Delek US's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	2,980	5,935	5,761	7,016	6,134	6,813	8,193	7,172	6,666	6,848
Total Current Assets	1,397	2,612	2,420	2,963	2,300	3,020	3,717	2,666	2,332	2,068
Cash & Equivalents	689	932	1,079	955	788	857	841	822	736	626
Accounts Receivable	266	582	514	793	528	777	1,234	784	618	649
Inventories, net	392	808	678	947	728	1,261	1,519	941	893	726
Other Current Assets	49	130	149	269	256	126	123	78	86	68
Plant, Property, & Equipment, net	1,103	2,141	2,195	2,428	2,367	2,307	2,776	2,696	2,940	3,273
Plant, Property & Equipment, gross	1,588	2,773	3,000	3,363	3,520	3,645	4,349	4,460	4,948	5,587
Accumulated Depreciation	484	632	805	935	1,152	1,338	1,573	1,764	2,008	2,314
Total Noncurrent Assets	480	1,183	1,145	1,625	1,467	1,486	1,700	1,810	1,394	1,507
Long-Term Investments	360	138	130	407	364	344	360	361	393	428
Goodwill	12	817	858	856	730	730	744	688	475	475
Intangible Assets	27	101	104	110	108	103	316	288	322	406
Other Noncurrent Operating Assets	81	127	53	251	266	309	280	246	204	199
Total Liabilities & Shareholders' Equity	2,980	5,935	5,761	7,016	6,134	6,813	8,193	7,172	6,666	6,848
Total Liabilities	1,797	3,971	3,953	5,181	5,009	5,799	7,123	6,212	6,091	6,300
Total Current Liabilities	935	2,672	1,664	2,356	1,903	3,127	3,086	2,685	2,516	2,529
Short-Term Debt	84	590	32	36	33	92	75	45	9.50	9.50
Accounts Payable	496	975	1,011	1,600	1,144	1,695	1,746	1,814	1,814	1,634
Other Current Liabilities	354	1,001	620	720	726	1,339	1,266	815	693	886
Total Noncurrent Liabilities	862	1,299	2,289	2,825	3,106	2,672	4,037	3,527	3,575	3,771
Long-Term Debt	749	875	1,751	2,031	2,315	2,126	2,979	2,555	2,756	3,224
Asset Retirement Reserve & Litigation Obligation	11	141	215	207	145	148	153	147	58	65
Noncurrent Deferred & Payable Income Tax Liabilities	76	200	210	268	256	215	267	264	215	218
Other Noncurrent Operating Liabilities	26	83	113	320	390	184	638	526	546	264
Total Equity & Noncontrolling Interests	1,183	1,964	1,808	1,835	1,125	1,014	1,070	960	575	547
Total Preferred & Common Equity	992	1,651	1,633	1,666	1,007	894	944	846	313	287
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	992	1,651	1,633	1,666	1,007	894	944	846	313	287
Common Stock	651	901	1,136	1,153	1,186	1,207	1,135	1,114	1,217	1,292
Retained Earnings	522	768	982	1,206	522	385	508	430	-206	-311
Treasury Stock	-161	-25	-514	-692	-694	-694	-694	-694	-694	-694
Noncontrolling Interest	191	314	176	169	118	120	126	114	262	261

This table presents Delek US's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026
Period end date	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026	6/30/2026
Total Assets	7,787	7,770	7,869	7,180	6,944	7,030	6,882	7,069	7,081	7,570	7,551
Total Current Assets	3,187	3,196	3,333	2,708	2,501	2,565	2,215	2,322	2,346	2,648	2,603
Cash & Equivalents	865	822	902	753	658	1,038	624	616	631	624	629
Accounts Receivable	848	1,004	1,167	832	771	562	649	743	667	943	866
Inventories, net	1,315	1,276	1,179	1,038	1,010	915	853	861	769	931	999
Other Current Assets	159	95	86	85	61	51	90	102	278	150	109
Plant, Property, & Equipment, net	2,882	2,869	2,835	2,804	2,786	2,829	3,187	3,249	3,231	3,411	3,433
Plant, Property & Equipment, gross	4,529	4,577	4,603	4,736	4,799	4,791	5,284	5,400	5,459	5,811	5,909
Accumulated Depreciation	1,647	1,708	1,768	1,932	2,014	1,962	2,097	2,151	2,228	2,400	2,477
Total Noncurrent Assets	1,718	1,704	1,701	1,668	1,657	1,637	1,480	1,498	1,504	1,511	1,516
Long-Term Investments	354	364	371	370	387	409	397	409	420	424	431
Goodwill	744	744	744	729	729	688	475	475	475	475	475
Intangible Assets	310	305	300	291	284	329	403	416	409	404	400
Other Noncurrent Operating Assets	309	291	285	277	256	212	205	198	200	207	209
Total Liabilities & Shareholders' Equity	7,787	7,770	7,869	7,180	6,944	7,030	6,882	7,069	7,081	7,570	7,551
Total Liabilities	6,662	6,707	6,712	6,145	5,961	6,085	6,453	6,774	6,636	7,268	7,129
Total Current Liabilities	2,870	2,915	3,003	2,607	2,565	2,467	2,592	2,906	2,715	3,495	3,411
Short-Term Debt	50	50	30	15	9.50	9.50	9.50	9.50	9.50	9.50	8.50
Accounts Payable	1,794	1,990	2,007	1,732	1,861	1,714	1,834	1,905	1,755	2,310	1,853
Other Current Liabilities	1,026	875	966	860	694	744	749	991	951	1,175	1,550
Total Noncurrent Liabilities	3,793	3,792	3,709	3,539	3,396	3,618	3,861	3,868	3,921	3,773	3,717
Long-Term Debt	2,726	2,761	2,609	2,482	2,452	2,780	3,026	3,091	3,168	3,174	3,181
Asset Retirement Reserve & Litigation Obligation	154	154	155	154	59	58	65	67	64	66	67
Noncurrent Deferred & Payable Income Tax Liabilities	284	281	304	270	262	244	191	177	214	160	152
Other Noncurrent Operating Liabilities	630	596	642	633	623	536	579	534	475	374	317
Total Equity & Noncontrolling Interests	1,124	1,063	1,157	1,035	983	875	429	295	445	302	423
Total Preferred & Common Equity	1,000	941	1,038	855	806	703	155	26	181	53	187
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,000	941	1,038	855	806	703	155	26	181	53	187
Common Stock	1,142	1,123	1,117	1,173	1,177	1,174	1,249	1,244	1,242	1,275	1,268
Retained Earnings	557	518	620	382	328	229	-395	-520	-363	-529	-388
Treasury Stock	-694	-694	-694	-694	-694	-694	-694	-694	-694	-694	-694
Noncontrolling Interest	124	122	119	180	177	172	274	269	264	250	236

This table displays calculated financial ratios and metrics derived from Delek US's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	-12.21%	73.11%	40.81%	-9.14%	-21.47%	45.83%	85.96%	-16.84%	-28.03%	-9.53%
EBITDA Growth	0.00%	-60.92%	651.49%	51.83%	-15.15%	-159.25%	160.76%	199.10%	-20.00%	-118.83%	725.56%
EBIT Growth	0.00%	-170.55%	859.07%	60.69%	-19.31%	-237.65%	97.19%	2,533.33%	-45.99%	-295.33%	160.74%
NOPAT Growth	0.00%	-128.78%	674.59%	144.31%	-16.30%	-226.68%	95.26%	1,653.38%	-23.43%	-219.08%	202.78%
Net Income Growth	0.00%	-405.26%	341.83%	16.21%	-10.32%	-270.67%	83.39%	404.83%	-83.92%	-1,215.42%	108.31%
EPS Growth	0.00%	-878.13%	260.64%	-1.25%	2.78%	-304.68%	79.18%	307.51%	-91.64%	-3,023.33%	95.67%
Operating Cash Flow Growth	0.00%	37.78%	28.91%	75.26%	2.66%	-149.18%	231.28%	14.51%	138.33%	-106.59%	902.10%
Free Cash Flow Firm Growth	0.00%	0.00%	-14.10%	135.69%	-39.47%	-219.69%	190.35%	-292.53%	306.03%	-138.07%	59.93%
Invested Capital Growth	0.00%	0.00%	138.65%	3.30%	6.63%	-8.56%	-12.53%	43.85%	-26.32%	2.73%	23.28%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	-0.09%	-2.01%	-5.21%	13.01%	4.91%	-4.42%	-14.49%	0.52%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	10.16%	-17.05%	-397.42%	422.44%	-18.25%	-7.94%	-163.51%	441.86%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	12.89%	-21.65%	-119.39%	94.78%	-25.92%	-18.72%	-142.24%	211.12%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	-23.36%	-18.29%	-100.25%	90.82%	-22.80%	-6.94%	-144.77%	289.20%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	-20.67%	-21.01%	-131.93%	74.83%	-26.47%	-51.91%	-86.77%	109.50%
EPS Q/Q Growth	0.00%	0.00%	0.00%	-29.08%	-20.39%	-117.54%	68.94%	-29.19%	-73.68%	-83.47%	95.30%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	60.73%	24.93%	-28.77%	-3.63%	13.54%	-51.52%	60.38%	-135.63%	510.57%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	-52.32%	37.53%	-38.52%	-38,575.05%	264.09%	-532.88%	65.66%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	-5.44%	1.73%	-14.41%	0.82%	16.79%	-14.63%	-3.35%	6.04%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	11.40%	0.76%	5.94%	9.51%	9.57%	-3.57%	2.35%	3.78%	3.33%	-0.36%	5.71%
EBITDA Margin	3.77%	1.68%	7.29%	7.86%	7.34%	-5.54%	2.31%	3.71%	3.57%	-0.93%	6.46%
Operating Margin	1.44%	-1.17%	2.48%	5.98%	5.29%	-10.03%	-0.33%	2.31%	1.49%	-4.15%	2.81%
EBIT Margin	1.47%	-1.18%	5.18%	5.91%	5.25%	-9.20%	-0.18%	2.32%	1.51%	-4.09%	2.75%
Profit (Net Income) Margin	0.91%	-3.18%	4.44%	3.66%	3.62%	-7.86%	-0.90%	1.47%	0.28%	-4.40%	0.40%
Tax Burden Percent	205.16%	34.10%	107.78%	77.22%	83.49%	74.77%	69.41%	90.27%	281.33%	73.78%	111.31%
Interest Burden Percent	30.30%	788.71%	79.50%	80.25%	82.49%	114.20%	726.46%	69.97%	6.68%	145.51%	13.20%
Effective Tax Rate	-74.18%	0.00%	-9.76%	20.99%	17.80%	0.00%	0.00%	17.53%	-18.07%	0.00%	-17.48%
Return on Invested Capital (ROIC)	0.00%	-7.13%	12.10%	20.63%	16.44%	-21.09%	-1.12%	15.23%	11.39%	-15.76%	14.32%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	84.37%	211.15%	-3.10%	5.73%	-27.52%	-7.53%	9.18%	-4.52%	-28.26%	-1.94%
Return on Net Nonoperating Assets (RNNOA)	0.00%	-15.43%	8.41%	-0.75%	2.01%	-17.68%	-7.79%	12.65%	-6.78%	-52.11%	-6.61%
Return on Equity (ROE)	0.00%	-22.56%	20.50%	19.88%	18.46%	-38.77%	-8.91%	27.89%	4.60%	-67.87%	7.71%
Cash Return on Invested Capital (CROIC)	0.00%	-207.13%	-69.79%	17.39%	10.02%	-12.14%	12.25%	-20.73%	41.69%	-18.45%	-6.54%
Operating Return on Assets (OROA)	0.00%	-1.66%	8.45%	10.35%	7.64%	-10.22%	-0.29%	6.13%	3.23%	-7.01%	4.36%
Return on Assets (ROA)	0.00%	-4.48%	7.24%	6.41%	5.26%	-8.73%	-1.47%	3.87%	0.61%	-7.53%	0.64%
Return on Common Equity (ROCE)	0.00%	-18.93%	17.22%	17.30%	16.71%	-35.00%	-7.92%	24.60%	4.06%	-51.22%	4.12%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-13.45%	19.54%	22.96%	20.18%	-57.00%	-10.66%	30.79%	5.52%	-166.53%	0.00%
Net Operating Profit after Tax (NOPAT)	120	-34	198	483	405	-513	-24	377	289	-344	354
NOPAT Margin	2.50%	-0.82%	2.72%	4.72%	4.35%	-7.02%	-0.23%	1.91%	1.75%	-2.90%	3.30%
Net Nonoperating Expense Percent (NNEP)	0.00%	-91.50%	-199.06%	23.72%	10.71%	6.44%	6.41%	6.05%	15.90%	12.50%	16.26%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	9.15%	8.12%	-10.30%	9.35%
Cost of Revenue to Revenue	88.60%	99.24%	94.06%	90.49%	90.43%	103.57%	97.65%	96.22%	96.67%	100.36%	94.29%
SG&A Expenses to Revenue	7.76%	2.53%	2.42%	2.42%	2.95%	3.21%	1.88%	1.58%	1.65%	2.13%	2.51%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	9.96%	1.93%	3.46%	3.53%	4.28%	6.45%	2.68%	1.47%	1.84%	3.78%	2.90%
Earnings before Interest and Taxes (EBIT)	70	-50	377	605	488	-672	-19	460	248	-485	295
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	180	71	530	804	683	-404	246	735	588	-111	693
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	1.42	1.37	1.30	1.08	1.14	1.84	1.86	3.74	6.22
Price to Tangible Book Value (P/TBV)	0.00	0.00	3.19	3.34	3.09	6.40	16.42	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.00	0.00	0.32	0.22	0.23	0.15	0.10	0.09	0.10	0.10	0.17
Price to Earnings (P/E)	0.00	0.00	8.10	6.58	6.96	0.00	0.00	6.74	79.62	0.00	0.00
Dividend Yield	3.68%	3.11%	2.09%	3.52%	3.92%	8.38%	0.00%	2.45%	3.75%	5.43%	3.44%
Earnings Yield	0.00%	0.00%	12.35%	15.20%	14.38%	0.00%	0.00%	14.84%	1.26%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	1.32	1.25	1.19	1.03	1.06	1.27	1.44	1.39	1.55
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.42	0.29	0.33	0.33	0.20	0.19	0.19	0.26	0.39
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	5.75	3.71	4.45	0.00	8.76	5.05	5.29	0.00	6.10
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	8.10	4.94	6.21	0.00	0.00	8.07	12.51	0.00	14.32
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	15.40	6.18	7.50	0.00	0.00	9.83	10.76	0.00	11.94
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	9.53	5.33	5.27	0.00	5.80	8.73	3.07	0.00	7.88
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	7.33	12.30	0.00	8.07	0.00	2.94	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.70	0.75	0.99	1.13	2.09	2.19	2.86	2.71	4.81	5.91
Long-Term Debt to Equity	0.00	0.63	0.45	0.97	1.11	2.06	2.10	2.79	2.66	4.79	5.89
Financial Leverage	0.00	-0.18	0.04	0.24	0.35	0.64	1.04	1.38	1.50	1.84	3.40
Leverage Ratio	0.00	2.52	2.83	3.10	3.51	4.44	6.05	7.20	7.57	9.02	12.04
Compound Leverage Factor	0.00	19.87	2.25	2.49	2.89	5.07	43.97	5.04	0.51	13.12	1.59
Debt to Total Capital	0.00%	41.33%	42.73%	49.65%	52.97%	67.61%	68.63%	74.06%	73.04%	82.78%	85.52%
Short-Term Debt to Total Capital	0.00%	4.19%	17.21%	0.89%	0.93%	0.96%	2.85%	1.81%	1.25%	0.28%	0.25%
Long-Term Debt to Total Capital	0.00%	37.14%	25.52%	48.76%	52.04%	66.65%	65.77%	72.25%	71.79%	82.50%	85.27%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	9.46%	9.14%	4.89%	4.33%	3.41%	3.71%	3.05%	3.21%	7.86%	6.90%
Common Equity to Total Capital	0.00%	49.22%	48.13%	45.46%	42.70%	28.98%	27.67%	22.89%	23.75%	9.36%	7.58%
Debt to EBITDA	0.00	11.81	2.77	2.22	3.03	-5.81	9.03	4.16	4.42	-24.98	4.67
Net Debt to EBITDA	0.00	-3.07	0.75	0.71	1.03	-2.96	4.14	2.52	2.41	-14.79	3.15
Long-Term Debt to EBITDA	0.00	10.62	1.65	2.18	2.98	-5.72	8.65	4.05	4.35	-24.89	4.66
Debt to NOPAT	0.00	-24.18	7.41	3.69	5.11	-4.58	-91.31	8.09	9.00	-8.04	9.14
Net Debt to NOPAT	0.00	6.28	2.00	1.19	1.74	-2.34	-41.89	4.91	4.91	-4.76	6.16
Long-Term Debt to NOPAT	0.00	-21.73	4.42	3.62	5.02	-4.52	-87.52	7.90	8.84	-8.01	9.12
Altman Z-Score	0.00	0.00	1.96	2.86	2.15	1.16	1.72	2.93	2.64	1.58	1.73
Noncontrolling Interest Sharing Ratio	0.00%	16.12%	16.02%	12.97%	9.46%	9.71%	11.14%	11.79%	11.83%	24.54%	46.61%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.00	1.49	0.98	1.45	1.26	1.21	0.97	1.20	0.99	0.93	0.82
Quick Ratio	0.00	1.02	0.57	0.96	0.74	0.69	0.52	0.67	0.60	0.54	0.50
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-1,001	-1,142	407	247	-295	267	-513	1,058	-403	-161
Operating Cash Flow to CapEx	96.51%	537.96%	185.98%	219.38%	144.96%	-105.09%	176.60%	151.89%	259.50%	-16.00%	103.20%
Free Cash Flow to Firm to Interest Expense	0.00	-18.39	-12.17	3.02	1.88	-2.35	1.95	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	3.45	4.56	3.41	4.15	4.39	-2.25	2.72	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	-0.12	3.71	1.58	2.26	1.36	-4.39	1.18	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	1.41	1.63	1.75	1.46	1.11	1.64	2.64	2.14	1.71	1.59
Accounts Receivable Turnover	0.00	15.78	17.15	18.67	14.23	11.06	16.33	19.69	16.32	16.92	16.94
Inventory Turnover	0.00	10.62	11.38	12.46	10.35	9.03	10.46	13.71	12.94	12.97	12.49
Fixed Asset Turnover	0.00	3.80	4.48	4.72	4.02	3.05	4.56	7.79	6.02	4.21	3.45
Accounts Payable Turnover	0.00	8.39	9.29	9.32	6.44	5.51	7.32	11.07	8.94	6.56	5.87
Days Sales Outstanding (DSO)	0.00	23.13	21.29	19.55	25.65	33.00	22.36	18.53	22.37	21.58	21.55
Days Inventory Outstanding (DIO)	0.00	34.38	32.06	29.29	35.26	40.41	34.90	26.62	28.20	28.14	29.23
Days Payable Outstanding (DPO)	0.00	43.49	39.29	39.15	56.67	66.21	49.84	32.96	40.81	55.66	62.23
Cash Conversion Cycle (CCC)	0.00	14.02	14.06	9.69	4.25	7.20	7.42	12.20	9.75	-5.94	-11.45
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	0.00	966	2,306	2,382	2,540	2,322	2,031	2,922	2,153	2,212	2,727
Invested Capital Turnover	0.00	8.69	4.44	4.37	3.78	3.00	4.89	7.99	6.49	5.43	4.34
Increase / (Decrease) in Invested Capital	0.00	966	1,340	76	158	-217	-291	891	-769	59	515
Enterprise Value (EV)	0.00	0.00	3,048	2,987	3,034	2,398	2,152	3,711	3,108	3,068	4,222
Market Capitalization	0.00	0.00	2,339	2,238	2,160	1,082	1,015	1,732	1,577	1,169	1,781
Book Value per Share	$0.00	$16.02	$20.26	$19.92	$22.45	$13.65	$12.06	$13.54	$13.22	$4.95	$4.77
Tangible Book Value per Share	$0.00	$15.39	$9.00	$8.18	$9.43	$2.30	$0.83	($1.67)	($2.03)	($7.66)	($9.90)
Total Capital	0.00	2,015	3,430	3,591	3,902	3,474	3,232	4,123	3,560	3,340	3,780
Total Debt	0.00	833	1,466	1,783	2,067	2,348	2,218	3,054	2,600	2,765	3,233
Total Long-Term Debt	0.00	749	875	1,751	2,031	2,315	2,126	2,979	2,555	2,756	3,224
Net Debt	0.00	-216	396	574	705	1,197	1,017	1,853	1,417	1,637	2,180
Capital Expenditures (CapEx)	187	46	172	255	397	269	210	280	391	418	519
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	-143	-402	-291	-312	-358	-871	-136	-796	-910	-1,078
Debt-free Net Working Capital (DFNWC)	0.00	546	530	789	644	430	-15	705	25	-175	-452
Net Working Capital (NWC)	0.00	462	-60	757	607	396	-107	631	-19	-184	-461
Net Nonoperating Expense (NNE)	76	99	-125	109	68	61	71	87	242	177	310
Net Nonoperating Obligations (NNO)	0.00	-216	342	574	705	1,197	1,017	1,853	1,194	1,637	2,180
Total Depreciation and Amortization (D&A)	110	120	153	199	194	268	265	275	340	375	398
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-3.41%	-5.52%	-2.84%	-3.35%	-4.90%	-8.18%	-0.69%	-4.84%	-7.68%	-10.05%
Debt-free Net Working Capital to Revenue	0.00%	13.01%	7.30%	7.71%	6.92%	5.88%	-0.14%	3.56%	0.15%	-1.47%	-4.21%
Net Working Capital to Revenue	0.00%	11.00%	-0.82%	7.40%	6.53%	5.43%	-1.00%	3.18%	-0.12%	-1.55%	-4.30%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$4.04	$0.00	$4.10	($8.26)	($2.75)	$3.63	$0.30	($8.77)	($0.38)
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	71.57M	0.00	75.85M	73.60M	73.98M	70.79M	65.41M	63.88M	60.70M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$4.00	$0.00	$4.06	($8.26)	($2.75)	$3.59	$0.30	($8.77)	($0.38)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	72.30M	0.00	76.57M	73.60M	73.98M	71.52M	65.98M	63.88M	60.70M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	83.92M	0.00	73.41M	73.78M	74.20M	66.94M	64.02M	62.51M	59.81M
Normalized Net Operating Profit after Tax (NOPAT)	48	-64	126	483	405	-424	-41	352	184	-188	223
Normalized NOPAT Margin	1.01%	-1.53%	1.74%	4.72%	4.35%	-5.81%	-0.38%	1.78%	1.12%	-1.59%	2.08%
Pre Tax Income Margin	0.45%	-9.32%	4.12%	4.74%	4.33%	-10.51%	-1.29%	1.63%	0.10%	-5.96%	0.36%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1.35	-0.91	4.01	4.48	3.72	-5.35	-0.14	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	2.30	-0.63	2.11	3.58	3.09	-4.08	-0.18	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	-2.23	-1.76	2.18	2.59	0.70	-7.49	-1.68	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	-1.28	-1.48	0.28	1.69	0.06	-6.22	-1.72	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	132.72%	-46.18%	26.97%	21.37%	25.82%	-17.08%	0.00%	27.13%	129.12%	-12.32%	143.19%
Augmented Payout Ratio	229.29%	-50.67%	34.72%	118.81%	78.79%	-17.41%	0.00%	93.77%	311.99%	-20.29%	326.56%

This table displays calculated financial ratios and metrics derived from Delek US's official financial filings.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	59,808,421.00	61,287,542.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	59,808,421.00	61,287,542.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-3.37	2.77
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-7.83%	-20.29%	-18.45%	-34.27%	-41.90%	-15.54%	-16.43%	-5.11%	2.35%	0.42%	47.83%
EBITDA Growth	-9.39%	-47.92%	-24.03%	-110.43%	-308.84%	-118.85%	-41.51%	1,809.01%	187.05%	-230.57%	668.38%
EBIT Growth	-18.44%	-80.12%	-72.78%	-157.78%	-154.78%	-516.78%	-963.04%	344.56%	140.61%	-44.12%	861.46%
NOPAT Growth	-18.30%	-82.55%	-73.05%	-149.55%	-159.39%	-530.82%	-828.26%	387.70%	155.90%	-42.53%	1,146.64%
Net Income Growth	-45.94%	-134.90%	-1,640.00%	-149.60%	-151.16%	-528.97%	-245.21%	388.59%	124.15%	-20.44%	299.89%
EPS Growth	-50.91%	-153.68%	-346.15%	-160.91%	-160.24%	-445.10%	-203.45%	344.17%	118.98%	-20.14%	253.98%
Operating Cash Flow Growth	131.22%	-57.81%	-150.89%	-104.99%	-280.07%	-137.43%	206.20%	303.70%	407.52%	838.94%	411.48%
Free Cash Flow Firm Growth	166.64%	150.62%	405.80%	-2.65%	-153.25%	-142.38%	-98.13%	-125.36%	-4.71%	4.72%	1,062.13%
Invested Capital Growth	-26.32%	-10.14%	-10.74%	-9.26%	2.73%	1.49%	-1.20%	12.37%	23.28%	-0.31%	7.68%
Revenue Q/Q Growth	-19.67%	-15.88%	6.01%	-11.09%	-28.99%	22.28%	4.64%	4.43%	-15.85%	9.21%	54.05%
EBITDA Q/Q Growth	-126.29%	258.00%	-17.88%	-128.88%	-930.82%	92.72%	337.55%	631.99%	-34.00%	-128.81%	652.18%
EBIT Q/Q Growth	-176.73%	118.49%	-59.58%	-999.26%	-238.30%	69.76%	68.04%	847.86%	-45.54%	-210.70%	268.88%
NOPAT Q/Q Growth	-165.16%	118.22%	-58.72%	-1,002.96%	-241.10%	69.75%	73.37%	1,146.88%	-35.70%	-179.52%	295.55%
Net Income Q/Q Growth	-217.63%	84.26%	-3.57%	-158.62%	-495.70%	60.58%	43.15%	316.20%	-50.15%	-296.60%	194.34%
EPS Q/Q Growth	-226.40%	79.52%	-13.73%	-106.90%	-440.00%	57.10%	36.69%	266.48%	-58.02%	-371.54%	181.14%
Operating Cash Flow Q/Q Growth	-79.01%	83.59%	-129.03%	55.37%	-656.94%	61.83%	182.37%	-14.40%	1,042.73%	-8.29%	-42.98%
Free Cash Flow Firm Q/Q Growth	331.24%	-55.50%	1.21%	-50.29%	-335.89%	64.59%	104.40%	-790.02%	-849.73%	66.96%	153.67%
Invested Capital Q/Q Growth	-14.63%	11.85%	-0.36%	-4.63%	-3.35%	10.50%	-3.00%	8.47%	6.04%	-10.65%	4.77%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	-3.34%	3.03%	1.65%	-0.66%	-9.70%	-2.41%	1.89%	13.78%	9.30%	-4.91%	8.93%
EBITDA Margin	-2.07%	3.88%	3.09%	-1.00%	-14.55%	-0.87%	1.97%	13.79%	10.82%	-2.85%	10.23%
Operating Margin	-4.31%	0.93%	0.39%	-4.01%	-19.25%	-4.76%	-1.21%	10.24%	6.78%	-6.76%	7.40%
EBIT Margin	-4.34%	0.95%	0.39%	-3.99%	-19.01%	-4.70%	-1.44%	10.28%	6.66%	-6.75%	7.40%
Profit (Net Income) Margin	-4.31%	-0.81%	-0.76%	-2.22%	-18.61%	-6.00%	-3.26%	6.75%	4.00%	-7.20%	4.41%
Tax Burden Percent	72.51%	70.00%	77.22%	38.55%	86.53%	81.28%	87.14%	82.89%	94.92%	76.70%	81.16%
Interest Burden Percent	136.97%	-120.81%	-250.37%	144.23%	113.15%	157.00%	260.45%	79.15%	63.27%	139.05%	73.40%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	16.98%	4.11%	0.00%	18.84%
Return on Invested Capital (ROIC)	-19.58%	4.02%	1.68%	-16.16%	-73.16%	-15.62%	-3.85%	37.33%	28.21%	-20.81%	29.41%
ROIC Less NNEP Spread (ROIC-NNEP)	-22.73%	0.91%	-0.66%	-14.85%	-81.01%	-19.77%	-7.67%	34.41%	25.03%	-23.96%	26.30%
Return on Net Nonoperating Assets (RNNOA)	-34.12%	1.23%	-0.98%	-19.12%	-149.37%	-45.74%	-20.95%	85.88%	85.10%	-135.93%	154.17%
Return on Equity (ROE)	-53.70%	5.26%	0.70%	-35.28%	-222.52%	-61.36%	-24.80%	123.20%	113.31%	-156.74%	183.58%
Cash Return on Invested Capital (CROIC)	41.69%	14.29%	15.02%	3.87%	-18.45%	-20.13%	-18.88%	-19.34%	-6.54%	7.41%	14.19%
Operating Return on Assets (OROA)	-9.29%	2.00%	0.83%	-7.42%	-32.56%	-7.60%	-2.22%	15.55%	10.56%	-10.02%	12.20%
Return on Assets (ROA)	-9.23%	-1.69%	-1.60%	-4.13%	-31.88%	-9.70%	-5.03%	10.20%	6.34%	-10.69%	7.27%
Return on Common Equity (ROCE)	-47.34%	4.52%	0.59%	-29.22%	-167.93%	-42.34%	-16.15%	78.34%	60.50%	-44.55%	54.36%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-5.93%	-9.34%	-39.67%	0.00%	-420.98%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-112	20	9.45	-85	-291	-88	-23	245	158	-126	245
NOPAT Margin	-3.02%	0.65%	0.28%	-2.80%	-13.47%	-3.33%	-0.85%	8.50%	6.50%	-4.73%	6.01%
Net Nonoperating Expense Percent (NNEP)	3.14%	3.12%	2.34%	-1.32%	7.85%	4.16%	3.82%	2.92%	3.18%	3.15%	3.11%
Return On Investment Capital (ROIC_SIMPLE)	-3.15%	0.58%	-	-	-8.71%	-2.54%	-0.69%	6.78%	4.18%	-3.60%	6.79%
Cost of Revenue to Revenue	103.34%	96.97%	98.35%	100.66%	109.70%	102.41%	98.11%	86.22%	90.70%	104.91%	91.07%
SG&A Expenses to Revenue	1.53%	1.95%	1.84%	2.31%	2.54%	2.33%	2.77%	2.66%	2.25%	1.66%	1.39%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	0.97%	2.10%	1.26%	3.34%	9.55%	2.35%	3.10%	3.53%	2.52%	1.85%	1.53%
Earnings before Interest and Taxes (EBIT)	-161	30	14	-121	-411	-124	-40	297	162	-179	302
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-77	122	106	-31	-314	-23	54	398	263	-76	418
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.86	2.18	1.95	1.72	3.74	6.06	49.47	10.73	6.22	51.34	16.63
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.10	0.12	0.10	0.09	0.10	0.08	0.12	0.18	0.17	0.25	0.26
Price to Earnings (P/E)	79.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	13.82
Dividend Yield	3.75%	4.01%	3.97%	5.28%	5.43%	6.74%	4.82%	3.16%	3.44%	2.26%	2.02%
Earnings Yield	1.26%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	7.24%
Enterprise Value to Invested Capital (EV/IC)	1.44	1.42	1.32	1.22	1.39	1.32	1.53	1.68	1.55	2.08	2.14
Enterprise Value to Revenue (EV/Rev)	0.19	0.22	0.20	0.20	0.26	0.28	0.34	0.41	0.39	0.47	0.45
Enterprise Value to EBITDA (EV/EBITDA)	5.29	7.18	6.36	16.04	0.00	0.00	0.00	33.90	6.10	7.94	5.45
Enterprise Value to EBIT (EV/EBIT)	12.51	26.66	24.10	0.00	0.00	0.00	0.00	0.00	14.32	21.17	9.40
Enterprise Value to NOPAT (EV/NOPAT)	10.76	37.27	33.91	0.00	0.00	0.00	0.00	0.00	11.94	29.32	10.29
Enterprise Value to Operating Cash Flow (EV/OCF)	3.07	4.36	4.93	14.91	0.00	0.00	0.00	0.00	7.88	4.80	4.30
Enterprise Value to Free Cash Flow (EV/FCFF)	2.94	9.41	8.28	30.05	0.00	0.00	0.00	0.00	0.00	28.10	15.66
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	2.71	2.41	2.50	2.95	4.81	7.07	10.51	7.14	5.91	10.54	7.55
Long-Term Debt to Equity	2.66	2.40	2.50	2.94	4.79	7.05	10.48	7.12	5.89	10.51	7.53
Financial Leverage	1.50	1.36	1.49	1.29	1.84	2.31	2.73	2.50	3.40	5.67	5.86
Leverage Ratio	7.57	6.93	7.19	7.09	9.02	9.60	10.97	10.15	12.04	19.76	20.37
Compound Leverage Factor	10.37	-8.37	-18.01	10.22	10.20	15.08	28.56	8.03	7.62	27.48	14.96
Debt to Total Capital	73.04%	70.69%	71.47%	74.69%	82.78%	87.61%	91.32%	87.72%	85.52%	91.33%	88.30%
Short-Term Debt to Total Capital	1.25%	0.41%	0.28%	0.25%	0.28%	0.27%	0.28%	0.26%	0.25%	0.27%	0.24%
Long-Term Debt to Total Capital	71.79%	70.28%	71.19%	74.43%	82.50%	87.33%	91.04%	87.46%	85.27%	91.06%	88.06%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	3.21%	5.09%	5.14%	6.49%	7.86%	7.91%	7.92%	7.29%	6.90%	7.16%	6.54%
Common Equity to Total Capital	23.75%	24.21%	23.39%	18.83%	9.36%	4.49%	0.77%	4.99%	7.58%	1.51%	5.16%
Debt to EBITDA	4.42	5.24	4.95	16.00	-24.98	-11.90	-10.56	24.86	4.67	4.98	3.18
Net Debt to EBITDA	2.41	2.88	2.85	7.71	-14.79	-7.90	-7.07	16.64	3.15	3.34	2.12
Long-Term Debt to EBITDA	4.35	5.21	4.93	15.95	-24.89	-11.86	-10.53	24.79	4.66	4.96	3.17
Debt to NOPAT	9.00	27.21	26.40	-19.84	-8.04	-6.71	-6.47	-17.00	9.14	18.37	6.00
Net Debt to NOPAT	4.91	14.96	15.20	-9.56	-4.76	-4.45	-4.33	-11.38	6.16	12.32	4.01
Long-Term Debt to NOPAT	8.84	27.05	26.30	-19.78	-8.01	-6.69	-6.45	-16.95	9.12	18.32	5.99
Altman Z-Score	2.45	2.47	2.44	2.10	1.61	1.53	1.42	1.69	1.67	1.33	1.79
Noncontrolling Interest Sharing Ratio	11.83%	14.09%	14.60%	17.20%	24.54%	30.99%	34.90%	36.41%	46.61%	71.58%	70.39%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.99	1.04	0.98	1.04	0.93	0.85	0.80	0.86	0.82	0.76	0.76
Quick Ratio	0.60	0.61	0.56	0.65	0.54	0.49	0.47	0.48	0.50	0.45	0.44
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	657	292	298	148	-350	-124	5.45	-38	-357	-118	63
Operating Cash Flow to CapEx	126.82%	435.25%	-56.28%	-21.01%	-85.65%	-47.49%	31.11%	40.82%	437.98%	245.79%	151.35%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	3.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	-0.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	-1.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	2.14	2.09	2.10	1.86	1.71	1.62	1.54	1.51	1.59	1.49	1.65
Accounts Receivable Turnover	16.32	18.66	17.41	16.04	16.92	15.35	14.29	17.36	16.94	13.49	14.98
Inventory Turnover	12.94	12.98	13.07	13.04	12.97	12.24	11.74	12.37	12.49	11.43	12.04
Fixed Asset Turnover	6.02	5.51	5.46	4.89	4.21	3.79	3.59	3.52	3.45	3.25	3.61
Accounts Payable Turnover	8.94	8.66	7.76	7.34	6.56	6.49	5.84	6.01	5.87	4.92	5.96
Days Sales Outstanding (DSO)	22.37	19.56	20.97	22.76	21.58	23.77	25.54	21.02	21.55	27.06	24.37
Days Inventory Outstanding (DIO)	28.20	28.13	27.93	27.99	28.14	29.82	31.08	29.51	29.23	31.95	30.32
Days Payable Outstanding (DPO)	40.81	42.16	47.04	49.72	55.66	56.26	62.55	60.78	62.23	74.22	61.24
Cash Conversion Cycle (CCC)	9.75	5.52	1.86	1.02	-5.94	-2.67	-5.93	-10.24	-11.45	-15.22	-6.56
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,153	2,408	2,400	2,289	2,212	2,444	2,371	2,572	2,727	2,437	2,553
Invested Capital Turnover	6.49	6.16	6.07	5.76	5.43	4.68	4.54	4.39	4.34	4.40	4.90
Increase / (Decrease) in Invested Capital	-769	-272	-289	-234	59	36	-29	283	515	-7.50	182
Enterprise Value (EV)	3,108	3,421	3,162	2,795	3,068	3,231	3,631	4,332	4,222	5,080	5,469
Market Capitalization	1,577	1,868	1,568	1,210	1,169	942	1,286	1,941	1,781	2,696	3,102
Book Value per Share	$13.22	$13.36	$12.56	$10.89	$4.95	$2.49	$0.43	$3.01	$4.77	$0.88	$3.04
Tangible Book Value per Share	($2.03)	($2.58)	($3.24)	($4.85)	($7.66)	($11.56)	($14.25)	($11.70)	($9.90)	($13.83)	($11.25)
Total Capital	3,560	3,532	3,445	3,735	3,340	3,465	3,396	3,622	3,780	3,485	3,612
Total Debt	2,600	2,497	2,462	2,789	2,765	3,035	3,101	3,177	3,233	3,183	3,190
Total Long-Term Debt	2,555	2,482	2,452	2,780	2,756	3,026	3,091	3,168	3,224	3,174	3,181
Net Debt	1,417	1,373	1,417	1,343	1,637	2,015	2,076	2,127	2,180	2,135	2,130
Capital Expenditures (CapEx)	72	38	86	103	191	131	165	108	115	188	174
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-796	-637	-712	-930	-910	-991	-1,190	-991	-1,078	-1,462	-1,429
Debt-free Net Working Capital (DFNWC)	25	116	-54	107	-175	-368	-575	-360	-452	-837	-800
Net Working Capital (NWC)	-19	102	-64	98	-184	-377	-584	-369	-461	-847	-808
Net Nonoperating Expense (NNE)	48	46	36	-18	111	70	67	51	61	65	65
Net Nonoperating Obligations (NNO)	1,194	1,373	1,417	1,343	1,637	2,015	2,076	2,127	2,180	2,135	2,130
Total Depreciation and Amortization (D&A)	84	92	92	91	96	101	94	101	101	103	116
Debt-free, Cash-free Net Working Capital to Revenue	-4.84%	-4.07%	-4.61%	-6.71%	-7.68%	-8.72%	-11.00%	-9.29%	-10.05%	-13.62%	-11.85%
Debt-free Net Working Capital to Revenue	0.15%	0.74%	-0.35%	0.77%	-1.47%	-3.23%	-5.31%	-3.37%	-4.21%	-7.80%	-6.63%
Net Working Capital to Revenue	-0.12%	0.65%	-0.41%	0.71%	-1.55%	-3.32%	-5.40%	-3.46%	-4.30%	-7.89%	-6.71%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($2.51)	($0.51)	($0.58)	($1.20)	($6.48)	($2.78)	($1.76)	$2.96	$1.20	($3.34)	$2.76
Adjusted Weighted Average Basic Shares Outstanding	65.41M	64.02M	64.21M	64.06M	63.88M	62.12M	60.51M	60.19M	60.70M	60.26M	61.32M
Adjusted Diluted Earnings per Share	($2.49)	($0.51)	($0.58)	($1.20)	($6.48)	($2.78)	($1.76)	$2.93	$1.23	($3.34)	$2.71
Adjusted Weighted Average Diluted Shares Outstanding	65.41M	64.02M	64.21M	64.06M	63.88M	62.12M	60.51M	60.94M	60.70M	60.26M	62.49M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	64.02M	64.13M	64.54M	63.20M	62.51M	60.73M	60.15M	60.05M	59.81M	61.29M	61.23M
Normalized Net Operating Profit after Tax (NOPAT)	-112	20	25	-79	-291	-88	-23	259	158	-126	245
Normalized NOPAT Margin	-3.02%	0.65%	0.73%	-2.59%	-13.47%	-3.33%	-0.85%	8.97%	6.50%	-4.73%	6.01%
Pre Tax Income Margin	-5.94%	-1.15%	-0.99%	-5.76%	-21.51%	-7.38%	-3.74%	8.14%	4.21%	-9.38%	5.43%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	-0.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	-0.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	129.12%	-102.17%	-57.37%	-22.77%	-12.32%	-9.84%	-8.90%	-13.78%	143.19%	570.64%	21.99%
Augmented Payout Ratio	311.99%	-269.82%	-117.13%	-37.11%	-20.29%	-21.00%	-20.86%	-31.52%	326.56%	1,010.09%	41.55%

Financials Breakdown Chart

Key Financial Trends

Delek US Holdings (NYSE: DK) had a sharp deterioration in Q1 2026 after a much stronger second half of 2025. Revenue fell year over year, margins moved deeply negative again, and the company posted a sizeable quarterly loss. At the same time, DK generated solid operating cash flow, which helped offset some of the earnings pressure. The balance sheet still carries a heavy debt load, and book equity remains thin.

What stands out over the last several quarters:

Q1 2026 operating cash flow was strong at $461.1 million, showing the business still converts some activity into cash even during a loss-making quarter.
DK ended Q1 2026 with $624.1 million in cash and equivalents, up slightly from the prior quarter.
Total current assets rose to $2.65 billion in Q1 2026 from $2.35 billion in Q3 2025, helped by higher receivables and inventory balances.
Net income improved materially from the very weak 2024 period to a profitable Q4 2025, when DK earned $97.1 million in consolidated net income.
Q3 2025 also showed healthy profitability, with $194.8 million in net income and $2.93 diluted EPS.
In 2025, the company demonstrated the ability to swing back to profitability when refining margins improved, suggesting earnings remain highly cyclical rather than permanently impaired.
Debt maturity management remains active, with large repayments and new issuance showing up repeatedly in cash flow statements.
Capital spending has remained meaningful, with quarterly PPE purchases generally in the $100 million to $190 million range in 2025 and 2026.
Q1 2026 revenue fell to $2.65 billion from $2.89 billion in Q3 2025 and $2.43 billion in Q4 2025, reflecting a weaker top line than late 2025.
The quarter was deeply unprofitable, with $201.3 million in net loss attributable to common shareholders and -$3.34 EPS.

Profitability trend: DK’s earnings remain highly volatile. After a weak 2024, the company turned profitable in Q3 and Q4 2025, but Q1 2026 reversed sharply with operating loss of $179.3 million and pre-tax loss of $248.9 million. That kind of swing is typical of refining businesses, but it also highlights how dependent DK is on margin conditions.

Balance sheet trend: Leverage is still the main concern. In Q1 2026, total liabilities were $7.27 billion versus equity of only $302 million including noncontrolling interests. Long-term debt stood at $3.17 billion, and current liabilities were also high at $3.49 billion. While cash is adequate, the balance sheet leaves limited margin for error if operating conditions weaken again.

Cash flow trend: Cash generation has been uneven but often better than net income suggests. DK produced positive operating cash flow in Q1 2026, Q4 2025, and Q3 2025, but those results have been supported by working-capital swings and financing activity. The company also paid meaningful cash interest, including $89.6 million in Q1 2026, which underlines the burden of its debt structure.

Bottom line: Delek US remains a cyclical, cash-generating refiner with the ability to post strong quarters when margins improve, but Q1 2026 shows that earnings can reverse quickly. Investors should focus on refining margins, debt reduction, and whether operating cash flow stays strong enough to support the balance sheet through another down cycle.

08/14/26 04:29 AM ETAI Generated. May Contain Errors.

Delek US Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Delek US's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Delek US's net income appears to be on a downward trend, with a most recent value of $43.30 million in 2025, falling from $43.70 million in 2015. The previous period was -$520.90 million in 2024. See Delek US's forecast for analyst expectations on what's next for the company.

Delek US's total operating income in 2025 was $301 million, based on the following breakdown:

Total Gross Profit: $612.10 million
Total Operating Expenses: $311.10 million

Over the last 10 years, Delek US's total revenue changed from $4.78 billion in 2015 to $10.72 billion in 2025, a change of 124.2%.

Delek US's total liabilities were at $6.30 billion at the end of 2025, a 3.4% increase from 2024, and a 250.5% increase since 2016.

In the past 9 years, Delek US's cash and equivalents has ranged from $625.80 million in 2025 to $1.08 billion in 2018, and is currently $625.80 million as of their latest financial filing in 2025.

Over the last 10 years, Delek US's book value per share changed from 0.00 in 2015 to 4.77 in 2025, a change of 477.1%.

Related Companies

Financial statements for NYSE:DK last updated on 8/5/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Delek US (DK) Financials

Financials Breakdown Chart

Key Financial Trends

Delek US Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Delek US (DK) Financials

Annual Income Statements for Delek US

Quarterly Income Statements for Delek US

Annual Cash Flow Statements for Delek US

Quarterly Cash Flow Statements for Delek US

Annual Balance Sheets for Delek US

Quarterly Balance Sheets for Delek US

Annual Metrics And Ratios for Delek US

Quarterly Metrics And Ratios for Delek US

Financials Breakdown Chart

Key Financial Trends

Delek US Financials - Frequently Asked Questions

When does Delek US's fiscal year end?

How has Delek US's net income changed over the last 10 years?

What is Delek US's operating income?

How has Delek US's revenue changed over the last 10 years?

How much debt does Delek US have?

How much cash does Delek US have?

How has Delek US's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools